News About: Pharm. Industry
Price cut measures by drug volume should be scrapped: Industry
Industry officials said that the current system of pricing adjustment by annual drug volume may not contribute to financial stability in national health insurance, claiming the system should be scrapped.
They argue...
Cancellation of “innovative drug firm” title undisclosed
The government in June last year selected 43 pharmaceutical companies as innovative pharmaceutical firms to spearhead growth and transparency in the sector. But the title is canceled if the firm is convicted of provid...
Handok to expand non-pharmaceutical business
Handok Pharmaceutical unveiled its plan to seek organic growth by expanding its non-pharmaceutical business in 2013 to diversify its business portfolio, looking for new cash sources.
The company is working to make ...
Korea, U.S. agrees to shorten reimburse notice by 20 days
The governments of Korea and the U.S. agreed that the reimbursement notice of pharmaceutical products and medical devices should be shorted by 20 days from this January, according to the Korea Drug Research Associatio...
Government urged to take bolder steps to rid corrupt practices
The government needs to consider heavier punishments over kickbacks, or rebates to effectively uproot the unethical rebate practice because it would not only establish a fair trade order in the drug market but contrib...
Korea’s 7 botanical drugs developed under Pharmaceutical Affairs Law: KPMA
The Korea Pharmaceutical Manufacturers Association (KPMA) said Wednesday that the nation’s 7 botanical drugs, including Dong-A’s Stillen and SK Chemicals’ Joins, are prescription drugs developed through a series of cl...
ISS backs split-off of Dong-A Pharm
The Institutional Shareholder Services (ISS) suggested Dong-A Pharm’s plan to split the company into holding and operating entities to simplify its corporate structure and boost investor interest, Dong-A officials sai...
MSD Korea begins recall of HDL cholesterol drugMSD Korea is recalling Tredaptive (laropiprant + nicotinic acid), its medicine to raise "good" HDL cholesterol levels here, after it failed to prevent heart problems in a large ...
|
Vice health minister to have meeting with CEOs of innovative firms tomorrow
All eyes are on the meeting to be held between the health vice minister Sohn Kun-ik and chief executive officers of innovative drug firms at the Korean Pharmaceutical Manufacturers Association on Jan. 17 as 15 of the ...
Dong-A signs agreement to establish JV in Mongolia
Top local drug maker Dong-A Pharmaceutical on Monday announced that it has signed an agreement with a Mongolia-based MEIC Co., an affiliated company of Bishrelt Group, to set up a joint venture to commercialize pharma...
